Avanos Medical (AVNS) FCF Margin (2013 - 2026)
Avanos Medical (AVNS) posted FCF Margin of 9.11% for Q1 2026, down 132.13% sequentially from 28.36% in Q4 2025, and down 2045.0% YoY from 0.47% in Q1 2025.
Avanos Medical (AVNS) FCF Margin (2013 - 2026) Analysis & Trends
Avanos Medical has reported FCF Margin for 14 years, with the latest figure at 9.11% in Q1 2026.
- Quarterly FCF Margin fell 2045.0% year-over-year to 9.11% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 5.24% (down 1307.0% YoY) and the FY2025 annual result came in at 10.42%, down 340.0% from the prior year.
- FCF Margin declined to 9.11% in Q1 2026 per AVNS's latest filing, from 28.36% in the prior quarter.
- Over five years, FCF Margin peaked at 36.36% in Q4 2024 and troughed at 9.11% in Q1 2026.
- A 5-year average of 8.42% and a median of 11.34% in 2025 frame the typical range for FCF Margin.
- The sharpest annual moves came in 2022 and 2024: FCF Margin tumbled 10806 bps in 2022, then jumped 3243 bps in 2024.
- Over 5 years, FCF Margin stood at 24.34% in 2022, then plunged by 84 bps to 3.92% in 2023, then jumped by 827 bps to 36.36% in 2024, then slipped by 22 bps to 28.36% in 2025, then plunged by 132 bps to 9.11% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 9.11%, 28.36%, and 3.94% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 15.81% |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 16.07% |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 23.50% |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 33.60% |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 14.10% |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 1.28% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 5.32% |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 18.73% |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn | -9.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.11% |
| Dec 31, 2025 | 28.36% |
| Sep 30, 2025 | 3.94% |
| Jun 30, 2025 | -2.40% |
| Mar 31, 2025 | 11.34% |
| Dec 31, 2024 | 36.36% |
| Sep 30, 2024 | 11.74% |
| Jun 30, 2024 | 12.75% |
| Mar 31, 2024 | -7.28% |
| Dec 31, 2023 | 3.92% |
| Sep 30, 2023 | 14.71% |
| Jun 30, 2023 | -3.90% |
| Mar 31, 2023 | -6.78% |
| Dec 31, 2022 | 24.34% |
| Sep 30, 2022 | 13.41% |
| Jun 30, 2022 | 13.40% |
| Mar 31, 2022 | -1.62% |
| Dec 31, 2021 | 132.40% |
| Sep 30, 2021 | 9.99% |
| Jun 30, 2021 | 5.10% |